12:00 AM
 | 
Dec 04, 2000
 |  BC Week In Review  |  Company News  |  Deals

ArQule, SmithKline Beecham deal

ARQL will use its Parallel Track drug discovery technology to identify and optimize one...

Read the full 48 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >